US Patent 11052135 Methods and compositions for treating hunter syndrome
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+430 characters)
Article
Patent abstract
The present invention provides, among other things, compositions and methods for CNS delivery of Idursulfase-beta, a human recombinant iduronate-2-sulfatase protein, for effective treatment of Hunter Syndrome. The compositions and methods provided by the present invention effectively reduce symptoms not only in brain and spinal cord but also in peripheral tissues including heart, liver, spleen, lung, and kidney.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110521350
Date of Patent
July 6, 2021
0Patent Application Number
160661870
Date Filed
December 21, 2016
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 22 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110521350
Date of Patent
July 6, 2021
0Patent Application Number
160661870
Date Filed
December 21, 2016
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11052135 Methods and compositions for treating hunter syndrome
Infobox
Is a
Patent jurisdiction
Patent number
11052135
Date of patent
July 6, 2021
Patent application number
16066187
Date Filed
December 21, 2016
Patent citations
Patent primary examiner
Find more entities like US Patent 11052135 Methods and compositions for treating hunter syndrome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.